Development of a New Lyophilized Live-Attenuated Measles-Rubella (MR) Vaccine Formulation Designed for Lower Cost Production in Africa
Fields of Study & Subjects
Virology and Viral Diseases
Immune responses and vaccinations
vaccines and immunoinformatics approaches
Publication details
- Publisher
- F1000 Research Ltd
- Publication date
- 19 August 2026
- Document type
- Preprint